tiprankstipranks
Livzon Pharmaceutical Group Inc Class H (HK:1513)
:1513
Hong Kong Market
1513
Livzon Pharmaceutical Group
RESEARCH TOOLSreports
Want to see HK:1513 full AI Analyst Report?

Livzon Pharmaceutical Group (1513) Ratios

1 Followers

Livzon Pharmaceutical Group Ratios

HK:1513's free cash flow for Q1 2026 was ¥0.66. For the 2026 fiscal year, HK:1513's free cash flow was decreased by ¥ and operating cash flow was ¥0.28. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.96 2.23 2.15 2.14 2.30
Quick Ratio
 1.77 2.02 1.89 1.88 2.02
Cash Ratio
 1.11 1.29 1.42 1.40 1.41
Solvency Ratio
 0.26 0.31 0.28 0.27 0.26
Operating Cash Flow Ratio
 0.41 0.43 0.39 0.40 0.37
Short-Term Operating Cash Flow Coverage
 0.91 1.01 1.21 1.75 1.71
Net Current Asset Value
¥ 7.05B¥ 7.92B¥ 6.87B¥ 6.99B¥ 7.06B
Leverage Ratios
Debt-to-Assets Ratio
 0.16 0.16 0.16 0.14 0.15
Debt-to-Equity Ratio
 0.26 0.28 0.28 0.25 0.26
Debt-to-Capital Ratio
 0.21 0.22 0.22 0.20 0.21
Long-Term Debt-to-Capital Ratio
 0.01 0.05 0.10 0.10 0.12
Financial Leverage Ratio
 1.67 1.73 1.76 1.78 1.79
Debt Service Coverage Ratio
 0.67 0.85 1.17 1.45 1.57
Interest Coverage Ratio
 51.07 42.50 32.10 23.66 24.10
Debt to Market Cap
 0.13 0.17 0.16 0.17 0.17
Interest Debt Per Share
 4.29 4.37 4.37 3.85 3.98
Net Debt to EBITDA
 -1.79 -1.76 -1.99 -2.36 -2.21
Profitability Margins
Gross Profit Margin
65.68%64.07%65.45%61.61%64.68%
EBIT Margin
22.02%22.03%24.51%19.99%19.23%
EBITDA Margin
24.52%26.68%29.38%26.75%24.39%
Operating Profit Margin
22.67%22.03%24.08%19.43%18.61%
Pretax Profit Margin
23.53%24.03%23.76%19.17%18.45%
Net Profit Margin
16.77%16.99%17.45%15.72%15.12%
Continuous Operations Profit Margin
19.91%20.24%19.51%15.27%15.48%
Net Income Per EBT
71.26%70.69%73.45%81.99%81.93%
EBT Per EBIT
103.77%109.07%98.66%98.66%99.15%
Return on Assets (ROA)
8.12%8.21%8.43%7.80%7.68%
Return on Equity (ROE)
13.95%14.19%14.87%13.91%13.76%
Return on Capital Employed (ROCE)
16.38%15.24%16.90%14.24%13.46%
Return on Invested Capital (ROIC)
11.35%10.85%12.11%10.22%10.33%
Return on Tangible Assets
8.45%8.56%8.69%7.98%7.98%
Earnings Yield
6.74%8.61%8.66%9.58%8.82%
Efficiency Ratios
Receivables Turnover
 3.52 3.32 3.60 3.48 3.13
Payables Turnover
 7.54 7.82 2.58 2.88 2.40
Inventory Turnover
 2.63 2.67 2.04 2.32 2.18
Fixed Asset Turnover
 2.74 2.65 2.60 2.72 2.75
Asset Turnover
 0.48 0.48 0.48 0.50 0.51
Working Capital Turnover Ratio
 1.41 1.31 1.31 1.32 1.46
Cash Conversion Cycle
 194.03 200.15 138.46 135.74 131.73
Days of Sales Outstanding
 103.68 110.05 101.46 104.98 116.73
Days of Inventory Outstanding
 138.77 136.78 178.66 157.60 167.34
Days of Payables Outstanding
 48.41 46.68 141.67 126.84 152.34
Operating Cycle
 242.45 246.83 280.13 262.58 284.07
Cash Flow Ratios
Operating Cash Flow Per Share
 3.68 3.47 3.24 3.49 2.97
Free Cash Flow Per Share
 3.09 2.84 2.62 2.61 1.96
CapEx Per Share
 0.59 0.63 0.62 0.88 1.01
Free Cash Flow to Operating Cash Flow
 0.84 0.82 0.81 0.75 0.66
Dividend Paid and CapEx Coverage Ratio
 1.49 2.04 1.56 1.35 1.10
Capital Expenditure Coverage Ratio
 6.23 5.54 5.22 3.96 2.95
Operating Cash Flow Coverage Ratio
 0.87 0.80 0.76 0.93 0.77
Operating Cash Flow to Sales Ratio
 0.28 0.27 0.25 0.26 0.22
Free Cash Flow Yield
9.41%11.09%10.12%11.90%8.47%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 14.84 11.61 11.55 10.44 11.34
Price-to-Sales (P/S) Ratio
 2.49 1.97 2.02 1.64 1.71
Price-to-Book (P/B) Ratio
 2.01 1.65 1.72 1.45 1.56
Price-to-Free Cash Flow (P/FCF) Ratio
 10.63 9.02 9.88 8.40 11.81
Price-to-Operating Cash Flow Ratio
 8.92 7.39 7.99 6.28 7.81
Price-to-Earnings Growth (PEG) Ratio
 -4.85 -8.67 1.73 3.55 1.54
Price-to-Fair Value
 2.01 1.65 1.72 1.45 1.56
Enterprise Value Multiple
 8.37 5.63 4.87 3.78 4.82
Enterprise Value
 24.02B 17.42B 16.92B 12.56B 14.85B
EV to EBITDA
 8.37 5.63 4.87 3.78 4.82
EV to Sales
 2.05 1.50 1.43 1.01 1.18
EV to Free Cash Flow
 8.76 6.86 7.02 5.17 8.11
EV to Operating Cash Flow
 7.35 5.62 5.68 3.86 5.36
Tangible Book Value Per Share
 16.48 16.61 15.39 14.97 15.00
Shareholders’ Equity Per Share
 16.35 15.56 15.07 15.09 14.86
Tax and Other Ratios
Effective Tax Rate
 0.15 0.16 0.18 0.20 0.16
Revenue Per Share
 13.19 12.99 12.84 13.36 13.52
Net Income Per Share
 2.21 2.21 2.24 2.10 2.04
Tax Burden
 0.71 0.71 0.73 0.82 0.82
Interest Burden
 1.07 1.09 0.97 0.96 0.96
Research & Development to Revenue
 0.06 0.07 0.09 0.11 0.11
SG&A to Revenue
 0.35 0.34 0.25 0.05 0.05
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 <0.01
Income Quality
 2.48 1.57 1.29 1.71 1.42
Currency in CNY